AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18997832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 17284732 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral lower limb suspension for 4 weeks
Number of subjects: 18
Study 17284732 — intervention group
Group type: COMPARATOR
Intervention: Control period (4 weeks)
Number of subjects: 18
Study 15207444 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Home Hospitalization Service (GHHS)
Number of subjects: 109
Study 15207444 — intervention group
Group type: COMPARATOR
Intervention: General Medical Ward (GMW)
Number of subjects: 109
Study 12362963 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 sessions of acceptance and commitment therapy (ACT) plus treatment as usual (TAU)
Number of subjects: 80
Study 12362963 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual (TAU)
Number of subjects: 80
Study 9838238 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue (2 ml applied to the axillary dissection area)
Number of subjects: 108
Study 9838238 — intervention group
Group type: COMPARATOR
Intervention: No fibrin glue (control group)
Number of subjects: 108
Study 8013699 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal transplantation
Number of subjects: 0
Study 2650723 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatinum, bleomycin, vindesine, mitomycin C)
Number of subjects: 100
Study 848228 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar sympathectomy
Number of subjects: 183
Study 848228 — intervention group
Group type: COMPARATOR
Intervention: Not operated (Control)
Number of subjects: 183
Study 30908374 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg fatigue procedure
Number of subjects: 24
Study 30908374 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk fatigue procedure
Number of subjects: 24
Study 30908374 — intervention group
Group type: COMPARATOR
Intervention: Control condition (rest)
Number of subjects: 24
Study 30908374 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg fatigue (knee extension)
Number of subjects: 24
Study 30908374 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk fatigue (trunk flexion)
Number of subjects: 24
Study 31750743 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic plantar fascia release (EPFR)
Number of subjects: 43
Study 31750743 — intervention group
Group type: COMPARATOR
Intervention: Cryosurgery (CS)
Number of subjects: 43
Study 31399442 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg once daily
Number of subjects: 1545
Study 31399442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1545
Study 28402866 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE) - 8-week moderate-intensity exercise training, 3 sessions/week
Number of subjects: 30
Study 28402866 — intervention group
Group type: COMPARATOR
Intervention: Placebo exercise (PE) - 8-week light-intensity stretching, 3 sessions/week
Number of subjects: 30
Study 26112229 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (n=59)
Number of subjects: 76
Study 26112229 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=17)
Number of subjects: 76
Study 26112229 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful dieters (n=27)
Number of subjects: 76
Study 26112229 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsuccessful dieters (n=32)
Number of subjects: 76
Study 23219937 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 179
Study 23219937 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 179
Study 22028060 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrohysterography (EHG)
Number of subjects: 144
Study 22028060 — intervention group
Group type: COMPARATOR
Intervention: External tocodynamometry (TOCO)
Number of subjects: 144
Study 19214552 — intervention group
Group type: EXPERIMENTAL
Intervention: Full macular translocation (FMT)
Number of subjects: 50
Study 19214552 — intervention group
Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 50
Study 17978324 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist out-patient treatment
Number of subjects: 167
Study 17978324 — intervention group
Group type: COMPARATOR
Intervention: In-patient psychiatric treatment
Number of subjects: 167
Study 17978324 — intervention group
Group type: COMPARATOR
Intervention: General out-patient treatment
Number of subjects: 167
Study 12790762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dosulepine (TCA) at doses of 50-250 mg
Number of subjects: 113
Study 12790762 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI) at doses of 20-80 mg
Number of subjects: 113
Study 12790762 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (Li) with plasma levels of 0.66±0.08 meq/l
Number of subjects: 113
Study 11124358 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical abortion with methotrexate 50 mg orally followed by misoprostol 800 microg vaginally
Number of subjects: 50
Study 11124358 — intervention group
Group type: COMPARATOR
Intervention: Surgical abortion under local anesthesia using manual vacuum aspiration
Number of subjects: 50
Study 11124358 — intervention group
Group type: COMPARATOR
Intervention: Surgical abortion
Number of subjects: 50
Study 11124358 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical abortion
Number of subjects: 50
Study 9614721 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural instillation of low-dose streptokinase
Number of subjects: 0
Study 9614721 — intervention group
Group type: COMPARATOR
Intervention: Standard drainage methods
Number of subjects: 0
Study 8335859 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 11
Study 8335859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 11
Study 8335859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 11
Study 8335859 — intervention group
Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 11
Study 2877571 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg famotidine at bedtime
Number of subjects: 303
Study 2877571 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg famotidine at bedtime
Number of subjects: 303
Study 2877571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study 29154131 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3)
Number of subjects: 289
Study 27064031 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhuanggu joint capsules combined with celecoxib capsules
Number of subjects: 432
Study 27064031 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhuanggu joint capsules alone
Number of subjects: 432
Study 27064031 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib capsules combined with Zhuanggu joint capsule simulants
Number of subjects: 432
Study 24882225 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally focused psychiatric (CFP) consultation service, two sessions
Number of subjects: 118
Study 24882225 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 118
Study 22186881 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 sessions of hope‐based substance abuse treatment
Number of subjects: 40
Study 22186881 — intervention group
Group type: COMPARATOR
Intervention: Waiting list for another term of treatment
Number of subjects: 40
Study 20232582 — intervention group
Group type: EXPERIMENTAL
Intervention: copper zinc malonate lotion plus 4% hydroquinone cream (twice daily) and tretinoin cream (once daily)
Number of subjects: 42
Study 18466615 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib (all doses combined)
Number of subjects: 44838
Study 18466615 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional nonselective NSAIDs
Number of subjects: 44838
Study 18466615 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 44838
Study 18466615 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 44838
Study 18466615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44838
Study 12146849 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent vigorous physical activity
Number of subjects: 1905
Study 12146849 — intervention group
Group type: COMPARATOR
Intervention: Sedentary activity
Number of subjects: 1905
Study 12146849 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical activity
Number of subjects: 1905
Study 12146849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous physical activity
Number of subjects: 1905
Study 12146849 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity at any specific anatomical location in the large bowel
Number of subjects: 1905
Study 9600495 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) (3.5%)
Number of subjects: 30
Study 9600495 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS) (0.9%)
Number of subjects: 30
Study 8020690 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation intervention
Number of subjects: 20
Study 8020690 — intervention group
Group type: COMPARATOR
Intervention: Attention-placebo control intervention
Number of subjects: 20
Study 2601834 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent subdural drain with subcutaneous reservoir
Number of subjects: 144
Study 2601834 — intervention group
Group type: COMPARATOR
Intervention: External closed system drainage
Number of subjects: 144
Study 2601834 — intervention group
Group type: COMPARATOR
Intervention: Aspiration and irrigation without any drainage
Number of subjects: 144
Study 5386267 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine eye drops
Number of subjects: 0
Study 5386267 — intervention group
Group type: COMPARATOR
Intervention: Guanethidine pretreatment
Number of subjects: 0
Study 29058477 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection technique (IT) education with 4-mm pen needle; intensive education and reinforcement for 6 months.
Number of subjects: 123
Study 29058477 — intervention group
Group type: COMPARATOR
Intervention: Control group received similar messages at study outset; no intensive education.
Number of subjects: 123
Study 26466482 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of 9 U rhGH every night for 7 days
Number of subjects: 32
Study 26466482 — intervention group
Group type: COMPARATOR
Intervention: Saline applied in control group
Number of subjects: 32
Study 23092148 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid etching
Number of subjects: 16
Study 23092148 — intervention group
Group type: COMPARATOR
Intervention: Laser etching
Number of subjects: 16
Study 21841050 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib, 40 mg i.v.
Number of subjects: 100
Study 19282146 — intervention group
Group type: EXPERIMENTAL
Intervention: New endpoint based on four ordered levels
Number of subjects: 0
Study 19282146 — intervention group
Group type: COMPARATOR
Intervention: Usual endpoints
Number of subjects: 0
Study 16904970 — intervention group
Group type: EXPERIMENTAL
Intervention: Open Repair
Number of subjects: 1603
Study 16904970 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Repair
Number of subjects: 1603
Study 16904970 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuralgia
Number of subjects: 1603
Study 16904970 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrence
Number of subjects: 1603
Study 16904970 — intervention group
Group type: COMPARATOR
Intervention: Medical Outcomes Study Short Form 36
Number of subjects: 1603
Study 15005825 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated soya protein with standardised levels of isoflavones, cotyledon soya fibres and soya phospholipids
Number of subjects: 143
Study 15005825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 11579373 — intervention group
Group type: EXPERIMENTAL
Intervention: Group training consisting of 12 physiotherapeutic or psychologically oriented sessions
Number of subjects: 301
Study 11579373 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 301
Study 11579373 — intervention group
Group type: EXPERIMENTAL
Intervention: Group training
Number of subjects: 301
Study 11579373 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 301
Study 9393568 — intervention group
Group type: COMPARATOR
Intervention: Palliative coeliac axis intra-arterial cyclic infusions (CAI) consisting of mitoxantrone 10 mg/m2 on day 1, folinic acid 170 mg/m2 and 5-FU 600 mg/m2 during days 2-4, and cis-platinum 60 mg/m2 on day 5 for up to 11 cycles.
Number of subjects: 52
Study 9393568 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant coeliac axis intra-arterial cyclic infusions (CAI) consisting of mitoxantrone 10 mg/m2 on day 1, folinic acid 170 mg/m2 and 5-FU 600 mg/m2 during days 2-4, and cis-platinum 60 mg/m2 on day 5 for up to 6 cycles.
Number of subjects: 52
Study 8322238 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled methacholine with dosimeter method (maximal dose 210 mumol)
Number of subjects: 16
Study 8322238 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled methacholine with tidal breathing method (730 mumol)
Number of subjects: 16
Study 8322238 — intervention group
Group type: COMPARATOR
Intervention: Comparison of dosimeter and tidal breathing methods
Number of subjects: 16
Study 2825567 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone aerosol (1 mg bid)
Number of subjects: 24
Study 2825567 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release theophylline (6.5 mg/kg bid)
Number of subjects: 24
Study 2825567 — intervention group
Group type: COMPARATOR
Intervention: Slow-release verapamil (120 mg bid)
Number of subjects: 24
Study 2825567 — intervention group
Group type: COMPARATOR
Intervention: Cromolyn (20 mg qid via spinhaler)
Number of subjects: 24
Study 2825567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 30872546 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral episiotomy (4 cm cut at crowning, 1-3 cm from midline, at a 60° angle)
Number of subjects: 710
Study 30872546 — intervention group
Group type: COMPARATOR
Intervention: No episiotomy
Number of subjects: 710
Study 30872546 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral episiotomy
Number of subjects: 710
Study 30872546 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral episiotomy and no episiotomy
Number of subjects: 710
Study 28449627 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg lornoxicam
Number of subjects: 120
Study 28449627 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg lornoxicam
Number of subjects: 120
Study 28449627 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg lornoxicam
Number of subjects: 120
Study 28449627 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 ml isotonic 0.9% NaCl solution)
Number of subjects: 120
Study 24434830 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational nursing intervention
Number of subjects: 196
Study 24434830 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 196
Study 23920524 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with a virtual patient (VP) simulation system
Number of subjects: 20
Study 23920524 — intervention group
Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 20
Study 22096437 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Helical Hip System (DHHS)
Number of subjects: 51
Study 22096437 — intervention group
Group type: COMPARATOR
Intervention: Dynamic Hip Screw (DHS)
Number of subjects: 51
Study 19167684 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum-based salvage chemotherapy, high-dose therapy, and autologous stem cell transplantation (ASCT) for PET-positive patients
Number of subjects: 59
Study 19167684 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy for PET-negative patients
Number of subjects: 59
Study 19167684 — intervention group
Group type: EXPERIMENTAL
Intervention: All PET-positive patients
Number of subjects: 59
Study 16394688 — intervention group
Group type: EXPERIMENTAL
Intervention: Open endotracheal suctioning (OES)
Number of subjects: 18
Study 16394688 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-circuit endotracheal suctioning (CES) at -200 mmHg
Number of subjects: 18
Study 16394688 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-circuit endotracheal suctioning (CES) at -400 mmHg
Number of subjects: 18
Study 15683148 — intervention group
Group type: EXPERIMENTAL
Intervention: Watch_PAT100 (ambulatory device with built-in actigraph)
Number of subjects: 228
Study 15683148 — intervention group
Group type: EXPERIMENTAL
Intervention: Watch_PAT100
Number of subjects: 228
Study 11311997 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic, monovalent, octameric HIV‐1 MN V3 peptide in aluminum hydroxide (alum) adjuvant administered by intramuscular delivery
Number of subjects: 33
Study 11311997 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of the vaccine (encapsulated in biodegradable micro‐spheres)
Number of subjects: 33
Study 11311997 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oral administration with parenteral boosting
Number of subjects: 33
Study 9159559 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lamotrigine monotherapy for up to 48 weeks
Number of subjects: 163
Study 8254181 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II (1.5 ng/kg per min)
Number of subjects: 8
Study 8254181 — intervention group
Group type: COMPARATOR
Intervention: Sham infusion
Number of subjects: 8
Study 8254181 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II (0.75 ng/kg per min)
Number of subjects: 8
Study 8254181 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II (1.5 ng/kg per min) after indomethacin pretreatment
Number of subjects: 8
Study 8254181 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Number of subjects: 8
Study 3696929 — intervention group
Group type: EXPERIMENTAL
Intervention: Categorical order presentation of slides
Number of subjects: 10
Study 3696929 — intervention group
Group type: COMPARATOR
Intervention: Random order presentation of slides
Number of subjects: 10
Study 30063180 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological suppression of norepinephrine activity
Number of subjects: 154
Study 30063180 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological suppression of acetylcholine activity
Number of subjects: 154
Study 30063180 — intervention group
Group type: EXPERIMENTAL
Intervention: Centroparietal P3 component of the EEG
Number of subjects: 154
Study 30063180 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic factors (ADRA2A and NET genes)
Number of subjects: 154
Study 26790036 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% lidocaine gel
Number of subjects: 40
Study 26790036 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine gel
Number of subjects: 40
Study 23849811 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulating Enteral Nutrition (IEN)
Number of subjects: 37
Study 23849811 — intervention group
Group type: COMPARATOR
Intervention: Standard Enteral Nutrition (SEN)
Number of subjects: 37
Study 22806208 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.2 mg/day orally for 7 days)
Number of subjects: 94
Study 22806208 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94
Study 20510577 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention training (n=20)
Number of subjects: 41
Study 20510577 — intervention group
Group type: COMPARATOR
Intervention: Control procedures (n=21)
Number of subjects: 41
Study 18717662 — intervention group
Group type: EXPERIMENTAL
Intervention: Portex reuseable bougie (R)
Number of subjects: 16
Study 18717662 — intervention group
Group type: COMPARATOR
Intervention: Portex single use bougie (S)
Number of subjects: 16
Study 18717662 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature at 10 degrees C
Number of subjects: 16
Study 18717662 — intervention group
Group type: COMPARATOR
Intervention: Temperature at 30 degrees C
Number of subjects: 16
Study 17176661 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiarity manipulation of alcohol-IAT target categories
Number of subjects: 0
Study 17176661 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit Association Task (IAT)
Number of subjects: 0
Study 15023660 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPUFA supplementation of standard formula
Number of subjects: 0
Study 15023660 — intervention group
Group type: COMPARATOR
Intervention: Breast milk
Number of subjects: 0
Study 10678340 — intervention group
Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 45
Study 10678340 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 45
Study 10678340 — intervention group
Group type: COMPARATOR
Intervention: Beta-blockers
Number of subjects: 45
Study 10678340 — intervention group
Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 45
Study 8776832 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g pectin
Number of subjects: 6
Study 8776832 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g pectin
Number of subjects: 6
Study 8776832 — intervention group
Group type: COMPARATOR
Intervention: 0 g pectin
Number of subjects: 6
Study 1468724 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic regimen 1
Number of subjects: 219
Study 1468724 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic regimen 2
Number of subjects: 219
Study 1468724 — intervention group
Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 219
Study 6385893 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 0
Study 6385893 — intervention group
Group type: COMPARATOR
Intervention: Attention control (placebo)
Number of subjects: 0
Study 30756302 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone coaching intervention
Number of subjects: 417
Study 30756302 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 417
Study 29654805 — intervention group
Group type: EXPERIMENTAL
Intervention: SER120 intranasal spray 0.83 mcg
Number of subjects: 1333
Study 29654805 — intervention group
Group type: EXPERIMENTAL
Intervention: SER120 intranasal spray 1.66 mcg
Number of subjects: 1333
Study 29654805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1333